These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo. Pini A; Runci Y; Falciani C; Lelli B; Brunetti J; Pileri S; Fabbrini M; Lozzi L; Ricci C; Bernini A; Tonello F; Dal Molin F; Neri P; Niccolai N; Bracci L Biochem J; 2006 Apr; 395(1):157-63. PubMed ID: 16398644 [TBL] [Abstract][Full Text] [Related]
4. Development of a receptor-based inhibitory penta-unit-conjugated peptide to enhance anthrax toxin neutralization. Lee SC; Yoon MY Int J Biol Macromol; 2020 Nov; 163():327-335. PubMed ID: 32619663 [TBL] [Abstract][Full Text] [Related]
5. Use of phage display and polyvalency to design inhibitors of protein-protein interactions. Mourez M; Collier RJ Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461 [TBL] [Abstract][Full Text] [Related]
6. Polyvalent inhibitors of anthrax toxin that target host receptors. Basha S; Rai P; Poon V; Saraph A; Gujraty K; Go MY; Sadacharan S; Frost M; Mogridge J; Kane RS Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13509-13. PubMed ID: 16938891 [TBL] [Abstract][Full Text] [Related]
7. Designing a polyvalent inhibitor of anthrax toxin. Mourez M; Kane RS; Mogridge J; Metallo S; Deschatelets P; Sellman BR; Whitesides GM; Collier RJ Nat Biotechnol; 2001 Oct; 19(10):958-61. PubMed ID: 11581662 [TBL] [Abstract][Full Text] [Related]
8. Peptide inhibitors MAP the way towards fighting anthrax pathogenesis. DeCathelineau AM; Bokoch GM Biochem J; 2006 Apr; 395(1):e1-3. PubMed ID: 16541485 [TBL] [Abstract][Full Text] [Related]
9. Peptide Probes Reveal a Hydrophobic Steric Ratchet in the Anthrax Toxin Protective Antigen Translocase. Colby JM; Krantz BA J Mol Biol; 2015 Nov; 427(22):3598-3606. PubMed ID: 26363343 [TBL] [Abstract][Full Text] [Related]
10. Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loops. Laffly E; Pelat T; Cédrone F; Blésa S; Bedouelle H; Thullier P J Mol Biol; 2008 May; 378(5):1094-103. PubMed ID: 18423488 [TBL] [Abstract][Full Text] [Related]
12. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling. Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973 [TBL] [Abstract][Full Text] [Related]
13. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates. Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514 [TBL] [Abstract][Full Text] [Related]
14. Identification of a lead small-molecule inhibitor of anthrax lethal toxin by using fluorescence-based high-throughput screening. Wei D; Bu Z; Yu A; Li F BMB Rep; 2011 Dec; 44(12):811-5. PubMed ID: 22189685 [TBL] [Abstract][Full Text] [Related]